NPI: 1629330469 · HARRISBURG, PA 17111 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/07/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/07/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,026 | $12K |
| 2019 | 3,790 | $7K |
| 2020 | 3,292 | $228K |
| 2021 | 7,326 | $567K |
| 2022 | 4,835 | $392K |
| 2023 | 2,251 | $234K |
| 2024 | 1,933 | $224K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 17,205 | 1,392 | $1.64M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 5,916 | 420 | $22K |
| A4657 | Syringe, with or without needle, each | 2,705 | 1,015 | $637.63 |
| J1756 | Injection, iron sucrose, 1 mg | 250 | 41 | $295.84 |
| J1270 | Injection, doxercalciferol, 1 mcg | 2,497 | 205 | $212.10 |
| 90674 | 17 | 17 | $5.63 | |
| 83540 | 103 | 98 | $0.00 | |
| 85041 | 185 | 179 | $0.00 | |
| 83970 | 128 | 116 | $0.00 | |
| 85048 | 183 | 177 | $0.00 | |
| 82947 | 12 | 12 | $0.00 | |
| 82108 | 13 | 13 | $0.00 | |
| 82728 | 102 | 100 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 17 | 16 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 17 | 17 | $0.00 |
| 83550 | 103 | 98 | $0.00 |